LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (NASDAQ:RGDX) today announced its President and CEO, Kathleen Danenberg, will provide a business overview, including an update on its ResponseDX™ PCR-based genetic tests, at the ROTH 20th Annual OC Growth Stock Conference at the Ritz Carlton Laguna Niguel, in Dana Point, California February 18–21. Ms. Danenberg will present on February 20 from 5:00 p.m. – 5:30 p.m. PT.
